Parkinson's disease symptoms: the patient's perspective.

Movement Disorders : Official Journal of the Movement Disorder Society
Marios PolitisPaola Piccini

Abstract

Patients suffering from Parkinson's disease (PD) will typically experience a range of motor and nonmotor symptoms during the course of their illness, each of which will affect a particular individual to varying degrees. However, patients' perceptions of troublesome symptoms often differ from the clinician's view, and these discrepancies can hamper effective management of PD. In this study, we have assessed 265 consecutive PD patients by asking them to rank their three most troublesome symptoms in the last 6 months, so to gain further insight from the impact of illness on patients' quality of life. Patients were divided into early (<6 years) and late PD groups (>/=6 years) from symptom onset. The division at 6 years was based on the mean time from symptom onset to the development of motor complications. In the early PD group, the 5 most prevalent complaints (ranked in descending order) are slowness, tremor, stiffness, pain, and loss of smell and/or taste. In the advanced PD group, fluctuating response to their medication (most common: wearing-off phenomenon followed by dyskinesia), mood changes, drooling, sleep problems (most common: middle and late night insomnia followed by daytime sleepiness), and tremor were the top 5. Our f...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Oct 26, 2000·Brain : a Journal of Neurology·A Schrag, N Quinn
Apr 10, 2002·Neurology·I ArnulfY Agid
Jun 1, 2002·Parkinsonism & Related Disorders·L M ShulmanW J Weiner
Sep 5, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Simon G ParkinTipu Z Aziz
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H EvansAndrew J Lees
Jul 1, 2005·Current Neurology and Neuroscience Reports·K Ray ChaudhuriP Martinez-Martin
Apr 28, 2006·Age and Ageing·V DhawanK Ray Chaudhuri
Jun 5, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Pablo Martinez-MartinK Ray Chaudhuri
Jul 25, 2007·Neurology·D VerbaanJ J van Hilten
Jul 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Kelvin L ChouKatie Kompoliti
Oct 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Dagmar VerbaanJacobus J van Hilten
Nov 13, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Sean S O'SullivanAndrew J Lees
Mar 11, 2008·Journal of Neural Transmission·R SakakibaraT Hattori
Jun 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Shibley RahmanMarjan Jahanshahi
Dec 23, 2008·Pain·A G BeiskeE Svensson
Apr 21, 2009·Lancet Neurology·K Ray Chaudhuri, Anthony H V Schapira
May 5, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Angelika Nebe, Georg Ebersbach
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneUNKNOWN PRIAMO study group
Jun 16, 2009·Lancet·Andrew J LeesTamas Revesz

❮ Previous
Next ❯

Citations

Feb 3, 2012·Journal of Neurology·Marios Politis, Paola Piccini
Dec 5, 2012·Journal of Neural Transmission·Giovanni DefazioMichele Tinazzi
Jan 23, 2013·Journal of Neural Transmission·Antonia Maass, Heinz Reichmann
Jan 12, 2012·Neuroscience Bulletin·Ruiping Xia, Zhi-Hong Mao
Oct 12, 2012·CNS Drugs·Munazza Sophie, Blair Ford
Aug 31, 2013·Lancet Neurology·Marjolein A van der MarckUNKNOWN IMPACT study group
Nov 3, 2011·The Neurologist·Ronald E WilsonUNKNOWN LEGATO Investigators
Nov 30, 2011·TheScientificWorldJournal·Marios Politis, Clare Loane
Oct 5, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·B R Bloem, F Stocchi
Aug 21, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M LouterS Overeem
Apr 12, 2012·Science Translational Medicine·Marios PolitisPaola Piccini
Mar 22, 2013·Therapeutic Advances in Endocrinology and Metabolism·Jacqueline A Bayliss, Zane B Andrews
Apr 25, 2013·PloS One·Antje HaehnerThomas Hummel
Jun 21, 2011·Parkinson's Disease·Antje HaehnerHeinz Reichmann
Feb 18, 2014·Current Treatment Options in Neurology·Atbin Djamshidian, Joseph H Friedman
Nov 12, 2014·Nature Reviews. Neurology·Marios Politis
Mar 8, 2014·International Archives of Medicine·Wafa RegraguiMohamed Yahyaoui
Mar 19, 2014·Parkinson's Disease·Seyed-Mohammad Fereshtehnejad, Johan Lökk
Apr 4, 2014·Journal of Neural Transmission·Lisa KlingelhoeferK Ray Chaudhuri
Jun 26, 2013·Neurochemical Research·Kai-Li MaJie-Jie Dai
Jun 16, 2011·The International Journal of Neuroscience·Dee E Silver, Philip O Buck
Jul 23, 2015·Disability and Rehabilitation·Laura Fogg-RogersSuzanne C Purdy
Jun 13, 2012·Current Medical Research and Opinion·Ullrich WüllnerJan Kassubek
Feb 14, 2013·Brain : a Journal of Neurology·Tao Wu, Mark Hallett
Dec 15, 2015·Molecular Neurobiology·Ling XuYing Bai
Jun 19, 2013·The International Journal of Neuroscience·Mark F Lew
Jun 4, 2011·Expert Opinion on Pharmacotherapy·Joseph H FriedmanLawrence H Sweet
Aug 4, 2015·Rehabilitation Research and Practice·Laura SpurgeonCath Sackley
Feb 17, 2015·Parkinson's Disease·Yair ZlotnikTanya Gurevich
Apr 23, 2015·Best Practice & Research. Clinical Anaesthesiology·Alin Schaumberg
Aug 24, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Fariborz RahimiMandar Jog
Aug 3, 2016·Clinical Medicine : Journal of the Royal College of Physicians of London·Gennaro PaganoMarios Politis
Aug 18, 2016·Journal of Rehabilitation Research and Development·Roongroj BhidayasiriChusak Thanawattano
Mar 15, 2011·Parkinsonism & Related Disorders·Martijn van der EijkBastiaan R Bloem
Nov 2, 2016·Parkinson's Disease·Marcelo Rezende Young BloodCarlos Henrique Ferreira Camargo
Jun 9, 2016·Chronic Illness·Nathalie DuroseauBhuma Krishnamachari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
David A GallagherAnette Schrag
Movement Disorders : Official Journal of the Movement Disorder Society
Marios PolitisPaola Piccini
© 2021 Meta ULC. All rights reserved